Nicotine alters the ectonucleotidases activities in lymphocytes: In vitro and in vivo studies

Biomedicine and Pharmacotherapy

Volumn 66, Issue 3, 2012, Pages 206-212

  Thomé, Gustavo Roberto ^a   Souza de Oliveira, Lizielle ^a   Schetinger, Maria Rosa Chitolina ^a   Morsch, Vera Maria ^a   Spanevello, Rosélia Maria ^b   Fiorenza, Amanda Maino ^a   Seres, Jonas ^a   Baldissarelli, Jucimara ^a   Stefanello, Naiara ^a   Pereira, Maria Ester ^a   Calgaroto, Nicéia Spanholi ^a   Pimentel, Victor Camera ^a   Leal, Daniela Bitencourt Rosa ^a   do Carmo Gonçalves Souza, Viviane ^a   Augusto dos Santos Jaques, Jeandre ^a   Leal, Claudio Alberto Martins ^a   Corrêa da Cruz, Ritiel ^a   Thiesen, Flávia Valladão ^c   Melazzo Mazzanti, Cinthia ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Adenosine deaminase; Lymphocytes; Nicotine; NTPDase

Indexed keywords

ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; COTININE; NICOTINE; PURINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE; LYMPHOCYTE COUNT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN HYDROLYSIS; RAT;

ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; COTININE; HYDROLYSIS; LYMPHOCYTES; MALE; NICOTINE; NUCLEOTIDASES; PURINES; RATS; RATS, WISTAR;

EID: 84860229534     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2011.09.014     Document Type: Article

References (41)

1. Sopori M.L., Kozak W. Mechanisms and effects of immunomodulation by cigarette smoke. J Neuroimmunol 1998, 81:138-146.
2. Sopori M.L., Kozak W., Savage S.M., Geng Y., Soszynski D., Kluger M.J., et al. Effect of nicotine on the immune system: possible regulation of immune responses by central and peripheral mechanisms. Psychoneuroendocrinology 1998, 23:189204.
3. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol Perspect Sci Soc 2002, 2:372-377.
4. McAllister-Sistilli C.G., Caggiula A.R., Knopf S., Christine A.R., Miller A.L., Donny E.C. The effects of nicotine on the immune system. Psychoneuroendrocrinology 1998, 23:175-187.
5. Duhant X., Schandené L., Bruyns C., Gonzalez N.S., Goldman M., Boeynaems J., et al. Extracellular adenine nucleotides inhibit the activation of human CD4+ T lymphocytes. J Immunol 2002, 169:15-21.
6. Burnstock G., Knight G.E. Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol 2004, 240:31-304.
7. Schetinger M.R.C., Morsch V.M., Bonan C.D., Wyse A.T.S. NTPDase and 5'-nucleotidase activities in physiological and disease conditions: new perspectives for human health. Bio Factor 2007, 30:1-22.
8. Ralevic V., Burnstock G. Involvement of purinergic signaling in cardiovascular diseases. Drug News Perspect 2003, 16:133-140.
9. Thomé G.R., Mazzanti C.M., Ahmed M., Corrêa M., Spanevello R.M., Maldonado P.A., et al. Activity of ectonucleotidases and adenosine deaminase in rats exposed to cigarette smoke. Inhal Toxicol 2009, 21:906-912.
10. Kunapuli S.P., Daniel J.L. P2 receptor subtypes in the cardiovascular system. Biochem J 1998, 336:513.
11. Ralevic V., Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 1998, 50:413.
12. Di Virgilio F., Chiozzi P., Ferrari D., Falzoni S., Sanz J.M., Morelli A., et al. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 2001, 97:587-600.
13. Daddona P.E., Kelley W.N. Human adenosine deaminase. J Biol Chem 1977, 252:110-115.
14. Burnstock G. Purinergic signaling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol 2002, 22:364-373.
15. Robson S.C., Sévigny J., Zimmermann H. The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signal 2006, 2:409-430.
16. Spychala J. Tumor-promoting functions of adenosine. Pharmacol Ther 2000, 87:161-173.
17. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation on mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1g. Scand J Clin Lab Invest Suppl 1968, 97:77-89.
18. Leal D.B.R., Streher C.A., Neu T.N., Bittencourt F.P., Leal C.A.M., Silva J.E.P., et al. Characterization of NTPDase (NTPDase 1; ecto-apyrase; ecto-diphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes. Biochim Biophys Acta 2005, 1721:9-15.
19. Chan K., Delfert D., Junger K.D. A direct colorimetric assay for the Ca2+-ATPase activity. Anal Biochem 1986, 157:375-380.
20. Giusti G. Adenosine deaminase. Methods of enzymatic analysis 1974, 1092-1099. Academic, New York. H.U. Bergmeyer (Ed.).
21. Cattaneoa R., Alegretti A.P., Sagebin F.R., Abreu C.M., Petersen G.O., Chatkin J.M., et al. Validação de método para determinação de cotinina em urina por cromatografia líquida de alta eficiência. Rev Bras Toxicol 2007, 19:21-27.
22. Bradford M.M.A. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
23. Abercrombie E.D., Keefe K.A., Difrischia D.S., Zigmond M.J. Differential effect of stress on in vivo dopamine release in striatum, nucleus acumbens, and medial frontal cortex. J Neurochemistry 1989, 52:1655-1658.
24. Ryder J.M. Determination of adenosine triphosphate and its breakdown products in fish products by high-performance liquid chromatography. J Agric Food Chem 1985, 33:678-680.
25. Scherer R., Augusti P.R., Steffens C., Bochi V.C., Hecktheuer L.H., Lazzari R., et al. Effect of slaughter method on postmortem changes of grass carp (Ctenopharyngodon idella) stored in ice. J Food Sci 2005, 70:348-353.
26. Lunkes G.I., Lunkes D., Stefanello F., Morsch A., Morsch V.M., Mazzanti C.M., et al. Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies. Thromb Res 2003, 109:189-194.
27. Damle R.N., Ghiotto F., Valetto A., Albesiano E., Fais F., Yan X.J., et al. B-Cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood 2002, 99:4087-4093.
28. Takahashi H.K., Iwagaki H., Hamano R., Kanke T., Liu K., Sadamori H., et al. The immunosuppressive effects of nicotine during human mixed lymphocyte reaction. Eur J Pharmacol 2007, 559:69-74.
29. Dombrowski K.E., Ke Y., Brewer K., Kapp J.A. Ecto-ATPase: an activation marker necessary for effector cell function. Immunol Rev 1998, 161:111-118.
30. Dwyer K., Deaglio S., Gao W., Friedman D., Strom T., Robson S. CD39 and control of cellular immune responses. Purinergic Signal 2007, 3:171-180.
31. Neher G.H. Nicotine-induced depression of lymphocyte growth. Toxicol Appl Pharmacol 1974, 27:253-258.
32. Ikehaia S., Pahwa R.N., Lunzer D.G., Good R.A., Modak M.J. Adenosine-5'-triphosphate-(ATP) mediated stimulation and suppression of DNA synthesis in lymphoid cells. I. Characterization of ATP responsive cells in mouse lymphoid organs. J Immunol 1981, 127:1834-1838.
33. Middlebrook A.J., Martina C., Chang Y., Lukas R.J., DeLuca D. Effects of nicotine exposure on T cell development in fetal thymus organ culture: arrest of T cell maturation. J Immunol 2002, 169:2915-2924.
34. Fishman R.F., Rubin A.L., Novogrodsky A., Stenzel K.H. Selective suppression of blastogenesis induced by different mitogens: effect of noncyclic adenosine-containing compounds. Cell Immunol 1980, 54:129-139.
35. Resta R., Thompson L.F.T. Cell signaling through CD73. Cell Signal 1997, 9:131-139.
36. Haskó G., Cronstein B.N. Adenosine: an endogenous regulator of innate immunity. Trends Immunol 2004, 25:33-39.
37. Pulte E.D., Broekman M.J., Olson K.E., Drosopoulos J.H.F., Kizer J.R., Islam N., et al. CD39/NTPDase-1 activity and expression in normal leukocytes. Thromb Res 2007, 121:309-317.
38. Filippini A., Taffs R.E., Sitkovsky M.V. Extracellular ATP in T lymphocyte activation: possible role in effector functions. Proc Natl Acad Sci 1990, 87:8267-8271.
39. Gems D., Partridge L. Stress-response hormesis and aging: " That which does not kill us makes us stronger" Cell Metab 2008, 7:200-203.
40. Jonas W.B., Ives J.A. Should we explore the clinical utility of hormesis?. Hum Exp Toxicol 2008, 27:123-127.
41. Furst A. Hormetic effects in pharmacology: pharmacological inversions as prototypes for hormesis. Health Physics 1987, 52:527-530.